Latest / The Real Investment Show Podcast

Is it Time to Short the Vaccine Makers?
(1/20/22) As vax mandates around the world begin to crumble, the shift to "normalcy" should restore economic productivity. Getting people back to work and restoring consumer confidence is what makes an economy grow. So, what about the vax-makers? Johnson & Johnson peaked in December, and has been on a downward trend ever since. Moderna has also been in a big correction since July; Pfizer has also peaked and is beginning to decline. Markets are already picking up on the "return to normalcy," and government spending in these companies comes to an end. There are a lot of "value companies" that…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.